PREVALENCE OF TORCH INFECTIONS AMONG WOMEN IN ANDIJAN REGION
Article Sidebar
Main Article Content
Abstract
TORCH infections remain one of the most significant public health problems affecting women of reproductive age due to their serious consequences for pregnancy outcomes and neonatal health. The acronym TORCH includes Toxoplasmosis, Other infections, Rubella, Cytomegalovirus, and Herpes simplex virus. These infections are often asymptomatic in women but may lead to miscarriage, congenital anomalies, stillbirth, and long term complications in newborns. The present study aims to analyze the prevalence and epidemiological characteristics of TORCH infections among women in the Andijan region of Uzbekistan. The research is based on retrospective analysis of laboratory diagnostic data, regional health statistics, and published scientific sources. The findings indicate a relatively high prevalence of cytomegalovirus and toxoplasmosis, especially among women aged 20 to 35 years. The study emphasizes the importance of early screening, preventive measures, and public awareness to reduce the burden of TORCH infections and improve maternal and child health outcomes in the region.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.
How to Cite
References
1.Remington, J. S., Klein, J. O., Wilson, C. B., Nizet, V., & Maldonado, Y. (2018). Infectious diseases of the fetus and newborn infant. Elsevier.
2.World Health Organization. (2022). Congenital infections: Global health impact. WHO Press.
3.Adylova, N. A., & Karimov, B. S. (2021). Epidemiological aspects of TORCH infections in Central Asia. Journal of Public Health Research, 10(3), 215–220.
4.Cunningham, F. G., Leveno, K. J., Bloom, S. L., et al. (2021). Williams obstetrics (26th ed.). McGraw Hill.
5.Cannon, M. J., Schmid, D. S., & Hyde, T. B. (2019). Review of cytomegalovirus seroprevalence and demographic characteristics. Reviews in Medical Virology, 29(3), e2034.
6.Robert-Gangneux, F., & Dardé, M. L. (2020). Epidemiology of toxoplasmosis. Clinical Microbiology Reviews, 33(2), e00064-19.
7.Plotkin, S. A. (2019). Rubella eradication. Vaccine, 37(2), 236–240.
8.Looker, K. J., et al. (2020). Global estimates of herpes simplex virus infections. PLoS ONE, 15(3), e0229118.
9.Maldonado, Y. A., & Read, J. S. (2021). Diagnosis, treatment, and prevention of congenital infections. Current Opinion in Pediatrics, 33(1), 128–135.
10.Kenneson, A., & Cannon, M. J. (2020). Review of risk factors for CMV infection. Epidemiologic Reviews, 42(1), 50–64.
11.Dunn, D., Wallon, M., Peyron, F., et al. (2019). Mother-to-child transmission of toxoplasmosis. The Lancet, 383(9921), 1105–1115.
12.Uzbek Ministry of Health. (2023). Annual health statistics report. Tashkent.